$4.08
0.6017.39%
At close: -
$4.00
-0.08-2.08%
After Hours: 7:10 PM EDT
Comments
Loading...
Phathom Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:PHAT | Benzinga
Phathom Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS
$-1.070
Quarterly Revenue
$28.52M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$81.86M
Analyze the earnings history of Phathom Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals | -$1.25 | — | — | — | $7.32M | — | — | — | 08/07/2025 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.11 | -$1.07 | -$1.07 | 0.00% | $1.91M | $29.02M | $28.52M | -1.73% | 05/01/2025 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.80 | -$1.08 | -$0.79 | 26.85% | $682.00K | $25.65M | $29.66M | 15.65% | 03/06/2025 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.54 | -$1.49 | -$1.05 | 29.53% | $0.00 | $12.61M | $16.35M | 29.67% | 11/07/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.84 | -$1.38 | -$1.25 | 9.42% | $0.00 | $5.81M | $7.32M | 26.06% | 08/08/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.89 | -$1.24 | -$1.42 | — | $0.00 | $2.05M | $1.91M | -6.73% | 05/09/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.33 | -$1.08 | -$1.39 | -28.70% | $0.00 | $410.00K | $682.00K | 66.34% | 03/07/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.32 | -$0.89 | -$0.76 | 14.61% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.33 | -$1.00 | -$0.84 | 16.00% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.07 | -$1.26 | -$0.89 | 29.37% | $0.00 | — | $0.00 | — | 05/10/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.95 | -$1.35 | -$1.33 | 1.48% | $0.00 | — | $0.00 | — | 02/28/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.98 | -$1.32 | -$1.32 | 0.00% | $0.00 | — | $0.00 | — | 11/08/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.00 | -$1.03 | -$1.33 | -29.13% | $0.00 | — | $0.00 | — | 08/02/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.96 | -$0.97 | -$1.07 | -10.31% | $0.00 | $210.00K | $0.00 | -100.00% | 05/10/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.58 | -$1.03 | -$0.95 | 7.77% | $0.00 | — | $0.00 | — | 03/01/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.02 | -$0.98 | -$0.98 | 0.00% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.64 | -$1.07 | -$1.00 | 6.54% | $0.00 | — | $0.00 | — | 08/10/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.62 | -$1.19 | -$0.96 | 19.33% | $0.00 | — | $0.00 | — | 05/11/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$3.97 | — | -$1.58 | — | $0.00 | — | $0.00 | — | 03/30/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.07 | — | -$1.02 | — | $0.00 | — | $0.00 | — | 11/10/2020 | Get Alert |
| PHAT | Phathom Pharmaceuticals | — | — | -$0.64 | — | — | — | $0.00 | — | 08/06/2020 | Get Alert |
Phathom Pharmaceuticals (PHAT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-01 | $-1.07 | $-1.07 | 0.00 % |
| Q4 | 2025-03-06 | $-0.79 | $-1.08 | 26.9 % |
| Q3 | 2024-11-07 | $-1.05 | $-1.49 | 29.5 % |
| Q2 | 2024-08-08 | $-1.25 | $-1.38 | 9.42 % |
Phathom Pharmaceuticals (PHAT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-01 | $28.52M | $29.02M | -1.73 % |
| Q4 | 2025-03-06 | $29.66M | $25.65M | 15.7 % |
| Q3 | 2024-11-07 | $16.35M | $12.61M | 29.7 % |
| Q2 | 2024-08-08 | $7.32M | $5.81M | 26.1 % |
FAQ
When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?
Phathom Pharmaceuticals (PHAT) is scheduled to report earnings on August 7, 2025. The last reported earnings were for reported on May 1, 2025 for Q1.
What were the latest earnings per share (EPS) for Phathom Pharmaceuticals (NASDAQ:PHAT)?
The Actual EPS was $-1.07, which hit the estimate of $-1.07.
What were Phathom Pharmaceuticals’s (NASDAQ:PHAT) revenues?
The Actual Revenue was $28.5M, which missed the estimate of $29M.
Browse earnings estimates, EPS, and revenue on all stocks.
